Patients with congenital factor V deficiency have decreased factor Xa binding sites on their platelets.
about
Inherited disorders of platelet alpha-granules.Factor V (Quebec): a bleeding diathesis associated with a qualitative platelet Factor V deficiencyIdentification of the MMRN1 binding region within the C2 domain of human factor V.Isolation and study of an acquired inhibitor of human coagulation factor V.Acquired hemophilia.Human thrombomodulin is not an efficient inhibitor of the procoagulant activity of thrombin.Inhibition of activated protein C by plateletsBiosynthesis of coagulation Factor V by a human hepatocellular carcinoma cell line.Coagulation factor Va binds to human umbilical vein endothelial cells and accelerates protein C activationSubcellular localization and secretion of factor V from human platelets.Acquired deficiencies of protein S. Protein S activity during oral anticoagulation, in liver disease, and in disseminated intravascular coagulationPlatelet receptor-mediated factor X activation by factor IXa. High-affinity factor IXa receptors induced by factor VIII are deficient on platelets in Scott syndrome.A case of coagulation factor V deficiency complicated with intracranial hemorrhageGenotype-phenotype correlation in combined deficiency of factor V and factor VIII.Activation of coagulation factor V by a platelet protease.Fibrinopeptide A cleavage and platelet release in whole blood in vitro. Effects of stimuli, inhibitors, and agitationRelationship between platelet secretion and prothrombin cleavage in native whole blood.Relationship between secretion of platelet Factor 4 and thrombin generation during in vitro blood clottingMembrane changes associated with platelet activation. Exposure of actin on the platelet surface after thrombin-induced secretion.Monoclonal immunoglobulin M lambda coagulation inhibitor with phospholipid specificity. Mechanism of a lupus anticoagulantHuman coagluation factor V purification and thrombin-catalyzed activationHuman platelets and factor XI. Localization in platelet membranes of factor XI-like activity and its functional distinction from plasma factor XIHuman coagulation factor Va is a cofactor for the activation of protein C.Characterization of an apparently synonymous F5 mutation causing aberrant splicing and factor V deficiency.Inhibition of the anticoagulant activity of protein S by prothrombin.Isolation and characterization of lipid-protein particles containing platelet factor 3 released from human platelets.Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders.THE PLATELET MEMBRANE AS A CATALYTIC SURFACE IN THROMBIN GENERATION: AVAILABILITY OF PLATELET FACTOR 1 AND PLATELET FACTOR 3*
P2860
Q33371665-E0A15ABF-4717-425C-AB79-F1F721F02A1CQ33478715-F99EA7F5-9A34-4696-9EAD-4AC6B6F18E67Q34353691-813D688C-F686-4B22-9C95-6BBAD18BF8C2Q34520485-0E5076A9-9B42-4AE9-9C19-D1B7E8F289DCQ34530406-18BDD769-388A-4127-97AA-6DEB9EAC6DA3Q34537279-41A92870-C95A-46CB-BF30-A1A0B67D0569Q34564489-CCAB608F-13D3-4FA0-AAB5-324D60335CB0Q34604957-6707DB34-82A6-41AC-9AED-A566E5A20290Q34612041-E64157F1-8ADF-4128-97A6-D308417B5192Q35469007-46E2B472-C467-44AE-A09D-1D8367B98B9AQ35587970-2E7D0B64-0696-424A-B810-C6BC1484DA57Q35814182-6959F2C3-1F0D-44CD-9C67-357FE06474E1Q35938546-C1DD9092-06E8-4054-ADA6-E2BACB749493Q36713533-9C9C7B49-F47D-4435-B073-A44665CF7BCBQ36987960-0324203B-A531-48F1-9554-8B934046D1A3Q36999425-A27D3ACF-8846-42E9-A289-854C7E9833C4Q37001801-F62C9333-6F2D-4606-8F59-5CD9AA6099ACQ37020066-8AA21FA9-BD0F-4B7A-B992-03EE5E07FC5CQ37023529-5B236AC7-6FEC-4196-A368-59A1C0C75C04Q37027827-D18D55F0-09E5-4D34-ABB5-E241AADD448AQ37028310-597021D8-0F12-452D-87D9-4EF484A2B693Q37038202-4617D616-241B-4648-B2D6-D16B0F57D31DQ37606370-C7C9A46E-FD03-402F-A81B-9B50F9F8BF08Q38932615-2B2DAC7A-83E5-4421-AA36-1F6E16C31C2FQ41018518-C0C70363-D199-4BEB-8417-39790177D5CFQ42054508-A99CFA0B-3C87-4633-9D9A-1E142B1A83ABQ45877007-3ED38422-9DDC-4BDF-AA62-827F7F3AA46BQ57977321-E851C090-3F2D-4E54-9CE0-7CF7FF3A98C5
P2860
Patients with congenital factor V deficiency have decreased factor Xa binding sites on their platelets.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 1978
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Patients with congenital facto ...... ding sites on their platelets.
@en
Patients with congenital facto ...... ding sites on their platelets.
@nl
type
label
Patients with congenital facto ...... ding sites on their platelets.
@en
Patients with congenital facto ...... ding sites on their platelets.
@nl
prefLabel
Patients with congenital facto ...... ding sites on their platelets.
@en
Patients with congenital facto ...... ding sites on their platelets.
@nl
P2093
P2860
P356
P1476
Patients with congenital facto ...... ding sites on their platelets.
@en
P2093
Majerus DW
Majerus PW
Miletich JP
P2860
P304
P356
10.1172/JCI109194
P407
P577
1978-10-01T00:00:00Z